nach oben

Erschienen in:

01.12.2012 | Case Report

Delayed enhanced hepatosplenic sarcoid nodules on computed tomography in an interferon-naïve hepatitis C patient: a case report and review of the literature

verfasst von: Takuhiro Ugajin, Hiroyuki Miyatani, Katsuhiko Matsuura, Shinya Ushimaru, Kiyoka Omoto, Mitsuhiro Nokubi, Tomohisa Ohkohchi, Yukio Yoshida

Erschienen in: Clinical Journal of Gastroenterology | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Abstract

A 77-year-old woman with chronic type C hepatitis was diagnosed with hypoechoic hepatosplenic nodules on ultrasonography. These lesions showed low density on precontrast computed tomography and delayed enhancement. Judging from laboratory data and images, the nodules were considered unlikely to represent malignancies and were followed conservatively. The hepatic lesions then increased in size and number. Sarcoidosis was diagnosed following liver biopsy. All nodules disappeared spontaneously within 6 years. Although some cases of interferon-induced sarcoidosis in patients with chronic hepatitis C or hepatitis C virus (HCV)-related cirrhosis have been reported recently, interferon-naïve cases are relatively rare. Delayed enhancement on computed tomography may reflect fibrosis of hepatic sarcoid lesions that have been histologically confirmed. Gastroenterologists managing patients with chronic HCV infection need to keep such cases in mind.

Blich M, Edoute Y. Clinical manifestations of sarcoid liver disease. J Gastroenterol Hepatol. 2004;19:732–7.PubMedCrossRef

Layden TJ, Kulik L. Hepatic manifestations of pulmonary diseases. Clin Liver Dis. 2002;6:969–79.PubMedCrossRef

Lefkowitch JH. Scheuer’s liver biopsy interpretation. 8th ed. Philadelphia: Saunders-Elsevier; 2010. p. 145–7.

Gaya DR, Thorburn D, Oien KA, Morris AJ, Stanley AJ. Hepatic granulomas: a 10 year single centre experience. J Clin Pathol. 2003;56:850–3.PubMedCrossRef

Snyder N, Martinez JG, Xiao SY. Chronic hepatitis C is a common associated with hepatic granulomas. World J Gastroenterol. 2008;14:6366–9.PubMedCrossRef

Leclerc S, Myers RP, Moussalli J, Herson S, Poynard T, Benveniste O. Sarcoidosis and interferon therapy: report of five cases and review of the literature. Eur J Intern Med. 2003;14:237–43.PubMedCrossRef

Goldberg HJ, Fiedler D, Webb A, Jagirdar J, Hoyumpa AM, Peters J. Sarcoidosis after treatment with interferon-α: a case series and review of the literature. Respir Med. 2006;100:2063–8.PubMedCrossRef

Faurie P, Broussolle C, Zoulim F, Trepo C, Seve P. Sarcoidosis and hepatitis C: clinical description of 11 cases. Eur J Gastroenterol Hepatol. 2010;22:967–72.PubMedCrossRef

Belgodere X, Viraben R, Gorguet B, Allaouchiche B, Lieutaud O, Maestracci D. Cutaneous sarcoidosis, Sjogren syndrome and autoimmune thyroiditis associated with hepatitis C virus infection. Eur J Dermatol. 1999;9:235–6.PubMed

10.

Hunt J, Gordon FD, Jenkins RL, Lewis WD, Khettry U. Sarcoidosis with selective involvement of a second liver allograft: report of a case and review of the literature. Mod Pathol. 1999;12:325–8.PubMed

11.

Koarada S, Uchida M, Tada Y, Ushiyama O, Suzuki N, Ohta A, et al. A case of Sjogren’s syndrome complicated by polymiositis and sarcoidosis with HLA-B7 and DR8. Jpn J Clin Immunol. 2000;23:141–7. (in Japanese with English abstract).CrossRef

12.

Bonnet F, Dubuc J, Morlat P, Delbrel X, Doutre MS, Witte SD, et al. Sarcoidosis and comorbidity: retrospective study of 32 cases. Rev Med Interne. 2001;22:619–23. (in French with English abstract).PubMedCrossRef

13.

Yamada S, Mine S, Fujisaki T, Ohnari N, Eto S, Tanaka Y. Hepatic sarcoidosis associated with chronic hepatitis C. J Gastroenterol. 2002;37:564–70.PubMedCrossRef

14.

Nagahama H, Higashi Y, Soejima M, Yotsumoto K, Samukawa T. A case of sarcoidosis exacerbated after acute hepatitis C. Nihon Kokyuki Gakkai Zasshi. 2002;40:594–8. (in Japanese with English abstract).PubMed

15.

Cossu A, Cossu PA, Carcassi A. Chronic polyarthritis in a patient affected by sarcoidosis and HCV chronic infection. Case report and review of the literature. Rheumatismo 2002;54:144–49 (in Italian with English abstract).

16.

Bonnet F, Morlat P, Dubuc J, Witte SD, Bonarek M, Bernard N, et al. Sarcoidosis-associated hepatitis C virus infection. Dig Dis Sci. 2002;47:794–6.PubMedCrossRef

17.

Baz K, Yazici AC, Kaya TI, Ikizoglu G, Ulubas B, Apat DD, et al. Neutrophilic dermatosis of the hands in association with chronic hepatitis C and sarcoidosis. Clin Exp Dermatol. 2003;28:377–9.PubMedCrossRef

18.

Ramos-Casals M, Mana J, Nordi N, Brito-Zeron P, Xaubet A, Sanchez-Tapias JM, et al. Sarcoidosis in patients with chronic hepatitis C virus infection. Medicine. 2005;84:69–80.PubMedCrossRef

19.

Takai A, Fujikawa H, Kawashima Y, Kitazawa E, Watabe H, Sato S, et al. Hepatic sarcoidosis found as a small liver SOL in a patient with type C cirrhosis. J Gastroenterol. 2005;40:769–70.PubMedCrossRef

20.

Kim TH, Joo JE. Spontaneous resolution of systemic sarcoidosis in a patient with chronic hepatitis C without interferon therapy. World J Gastroenterol. 2006;12:150–3.PubMed

21.

Girvin F, Vlahos L. A 30-year-old man with a history of polysubstance abuse and hepatitis C presents with exertional dyspnea and patchy ground-glass opacities. Chest. 2006;130:1608–11.PubMedCrossRef

22.

Paul WE, Seder RA. Lymphocyte responses and cytokines. Cell. 1994;76:241–51.PubMedCrossRef

23.

Bertoletti A, D’Elios MM, Boni C, Carli MD, Zignego AL, Durazzo M, et al. Different cytokine profiles of intrahepatic T cells in chronic hepatitis B and hepatitis C virus infections. Gastroenterology. 1997;112:193–9.PubMedCrossRef

24.

Brinkmann V, Geiger T, Alkan S, Heusser CH. Interferon α increases the frequency of interferon γ-producing human CD4+ T cells. J Exp Med. 1993;178:1655–63.PubMedCrossRef

25.

Moller DR. Cells and cytokines involved in the pathogenesis of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 1999;16:24–31.PubMed

26.

Raanani P, Ben-Bassat I. Immune-mediated complications during interferon therapy in hematological patients. Acta Haematol. 2002;107:133–44.PubMedCrossRef

27.

Abdi EA, Nguyen GK, Ludwig RN, Dickout WJ. Pulmonary sarcoidosis following interferon therapy for advanced renal cell carcinoma. Cancer. 1987;59:896–900.PubMedCrossRef

28.

Nagano M. Inhibitory effect of captopril on cell degeneration and growth. Exp Clin Cardiol. 2006;11:195–7.PubMed

29.

Itai Y, Ohtomo K, Kokubo T, Yamaguchi T, Minami M, Yashiro N, et al. CT of hepatic masses: significance of prolonged and delayed enhancement. AJR. 1986;146:729–33.PubMed

30.

Yoshikawa J, Matsui O, Kadoya M, Gabata T, Arai K, Takashima T. Delayed enhancement of fibrotic areas in hepatic masses: CT-pathologic correlation. J Comput Assist Tomogr. 1992;16:206–11.PubMedCrossRef

31.

Shijubo N, Morita S, Itoh T, Takahashi R, Shigehara K, Yamada G, et al. Analysis of several examinations in 516 histologically proven sarcoidosis patients. Jpn J Sarcoidosis Other Granulomatous Disord. 2007;27:29–35. (in Japanese with English abstract).

32.

Thanos L, Zormpala A, Brountzos E, Nikita A, Kelekis D. Nodular hepatic and splenic sarcoidosis in a patient with normal chest radiograph. Eur J Radiol. 2002;41:10–1.PubMedCrossRef

33.

William SH, Fenton S, J Edward B. Bockus gastroenterology. 5th ed. Philadelphia: Saunders; 1995. p. 2320.

Titel: Delayed enhanced hepatosplenic sarcoid nodules on computed tomography in an interferon-naïve hepatitis C patient: a case report and review of the literature
verfasst von: Takuhiro Ugajin
Hiroyuki Miyatani
Katsuhiko Matsuura
Shinya Ushimaru
Kiyoka Omoto
Mitsuhiro Nokubi
Tomohisa Ohkohchi
Yukio Yoshida
Publikationsdatum: 01.12.2012
Verlag: Springer Japan
Erschienen in: Clinical Journal of Gastroenterology / Ausgabe 6/2012
Print ISSN: 1865-7257
Elektronische ISSN: 1865-7265
DOI: https://doi.org/10.1007/s12328-012-0337-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2012

Acute pancreatitis caused by an ectopic mediastinal parathyroid adenoma

Intraductal tubulopapillary neoplasm of the pancreas with somatic BRAF mutation

Anticoagulation therapy dramatically improved severe sigmoiditis with findings resembling inflammatory bowel disease, which was caused by mesenteric venous thrombosis

Advanced diffuse malignant peritoneal mesothelioma responding to palliative chemotherapy

Septicemia due to Vibrio cholerae serogroup non-O1/non-O139 strain in a cirrhotic patient